Word

TEIKOKU PHARMA

Status

Registered

Status Code

708

Status Date

Thursday, November 21, 2019

Serial Number

79123060

Registration Number

4416497

Registration Date

Tuesday, October 15, 2013

Mark Type

4000

Filing Date

Thursday, September 20, 2012

Published for Opposition

Tuesday, July 30, 2013

Trademark Owner History

Teikoku Pharma USA, Inc. - Original Registrant
Teikoku Pharma UK Limited - Original Applicant

Classifications

5 Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions

3 [ Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; soaps for personal use; perfumery; essential oils; hair lotions ]

42 Pharmaceutical research and development; pharmaceutical product evaluation, testing and inspection services; providing medical and scientific research information in the field of pharmaceuticals; information, advisory and consultancy services relating to all the aforesaid services

Color is not claimed as a feature of the mark.
The English translation of "TEIKOKU" in the mark is "EMPIRE".
"PHARMA"

Trademark Events

Sep 15, 2023

Teas Section 71 & 15 Received

Oct 15, 2022

Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed

Oct 6, 2022

International Registration Renewed

Oct 17, 2020

Partial Invalidation Processed By The Ib

Sep 5, 2020

Partial Invalidation Of Reg Ext Protection Sent To Ib

Aug 26, 2020

Invalidation Processed

Jul 21, 2020

Partial Invalidation Of Reg Ext Protection Created

Nov 21, 2019

Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed

Nov 21, 2019

Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.

Nov 21, 2019

Case Assigned To Post Registration Paralegal

Oct 14, 2019

Teas Section 71 & 15 Received

Oct 15, 2018

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Jan 9, 2017

Teas Change Of Correspondence Received

Apr 10, 2014

Final Decision Transaction Processed By Ib

Mar 3, 2014

Final Disposition Notice Sent To Ib

Mar 3, 2014

Final Disposition Processed

Jan 15, 2014

Final Disposition Notice Created, To Be Sent To Ib

Oct 15, 2013

Registered-Principal Register

Jul 30, 2013

Published For Opposition

Jul 10, 2013

Notice Of Publication

Jun 24, 2013

Law Office Publication Review Completed

Jun 17, 2013

Approved For Pub - Principal Register

May 30, 2013

Teas/Email Correspondence Entered

May 30, 2013

Correspondence Received In Law Office

May 22, 2013

Assigned To Lie

May 20, 2013

Teas Response To Office Action Received

May 11, 2013

Change Of Owner Received From Ib

Feb 27, 2013

Refusal Processed By Ib

Jan 28, 2013

Non-Final Action Mailed - Refusal Sent To Ib

Jan 28, 2013

Refusal Processed By Mpu

Jan 26, 2013

Non-Final Action (Ib Refusal) Prepared For Review

Jan 25, 2013

Non-Final Action Written

Jan 18, 2013

Assigned To Examiner

Jan 15, 2013

Application Filing Receipt Mailed

Jan 9, 2013

New Application Office Supplied Data Entered

Jan 3, 2013

Sn Assigned For Sect 66a Appl From Ib